From the Laboratory to Leadership turns science-minded managers into capable business leaders. That means they'll get the core management skills they need to fully leverage your company's human capital. In this four-day program, developed exclusively for managers in scientific fields, participants will learn how to … -Create productive teams in a challenging matrix-based team environment -Clearly...
Autoimmune and Inflammatory Disease During four days of face-to-face online meetings, leading researchers, top biotechs and biopharmaceutical companies will meet, network and partner to accelerate immunology pipelines and bring new treatment options to patients worldwide. Immunology Virtual Partnering is organized by Inova Software & BIO Click Here for More Information
Course Description This course teaches fundamental concepts in viral vectors for gene therapy and how to manufacture them. The course utilizes case studies and laboratory practices to demonstrate critical steps in the production of viral vectors. Instructors Dr. David McNally (MassBiologics), Dr. Phillip Tai (UMass Medical School), Dr. Shekar Ganesa (MassBiologics), Dr. Sangmook Lee (MassBiologics),...
The Annual Pharma Supply Chain and Security World Summit is now online, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain in a Global platform. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted,...
Identification of the metabolites is a major component in drug metabolism studies and is critical for both drug discovery and drug development. It requires careful strategic planning, utilization of modern analytical techniques in LCMS and NMR, and in-depth data analysis and interpretation. Deep understanding of the fundamentals of drug metabolism and organic chemistry is essential...
Save the date! Join us virtually on Tuesday, March 9th for a webinar and panel discussion with team members from California Institute of Regenerative Medicine (CIRM). Throughout the webinar, CIRM will cover their areas of interest, funding opportunities, portfolio of companies, along with an interactive panel discussion. Space is limited and registration is required. Representatives from CIRM will attend...
San Diego Member CEOs: Join us for a small monthly roundtable with Biocom California CEO Joe Panetta. Each session is an opportunity for 10 San Diego CEOs to connect with peers and discuss pressing issues facing our industry. It’s also an opportunity for Biocom California to learn more about your companies, your needs and how...
Ultrapure water is an important staple to life science labs. The water system is expected to deliver water that is free of impurities, has consistent quality and always available upon demand. This webinar investigates the different types of impurities in water and how water systems remove these critical impurities. We will also review guidelines for...
One measure of impact of a new protocol on a field is its use in clinical trials and in the clinic. A quick search of the impact of “precision medicine” in ClinicalTrials.gov results in hundreds of hits. Narrowing down to “recruiting” yields over 180 hits in areas as diverse as cancer, kidney disease, diabetes, mental...
Key Learning Objectives The safety challenges of undersized and oversized rAAV vectors and design strategies to address them. The impact of rAAV vector design on manufacturing productivity and batch potency. The contribution of rAAV vector design to the therapeutic sequence expression level and persistence in the target tissue. Audience Head of Research and Development Viral...
CLSA’s Life Sciences Academy is dedicated to educating policy makers and opinion leaders about our industry and how it operates, increasing their awareness of California’s life sciences industry’s most pressing issues in serving patients and improving the quality of life for residents across California. For the first time, due to the on-going pandemic, the 2021...
Dr. Perez will describe how a multidisciplinary team of Professors from the University of British Columbia (UBC) have combined machine learning, computer assisted drug design, structural biophysics, and human virology to identify molecules that may be developed for SARS-CoV-2 antiviral treatment.
